产品编号:B710035
产品规格:250mg
产品价格:面议
| 标准品编号: | B710035 |
| 名称: | Butyl 2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic Acid Ester |
| 别名: | Butyl 2-(3-Cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate; |
| CAS号: | 1619982-02-3 |
| 分子式: | C₂₀H₂₄N₂O₃S |
| 外观: | Off-Wite Solid |
| 熔点: | 115-117°C |
| 分子量: | 372.48 |
| 储存: | 冰箱保存 |
| 溶解度: | DMSO (Slightly), Methanol (Slightly) |
| 类别: | Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | Butyl 2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic Acid Ester is derived from Febuxostat (F229000), which is a xanthine oxidase/xanthine dehydrogenase inhibitor and used for treatment of hyperuricemia and chronic gout. 40-120 mg/day febuxostat was proven effective in lowering serum urate levels when administered to manage hyperuricemia in patients with gout. |
| 参考文献 | |